BAJAJ BROKING

Notification close image
No new Notification messages
card image
Anlon Healthcare Ltd IPO is open
Apply for the Anlon Healthcare Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

Amanta Healthcare IPO: Things Smart Investors Need to Know

Amanta Healthcare Limited, established in December 1994, is a pharmaceutical company focused on the development, manufacturing, and marketing of a wide range of sterile liquid products, primarily parenteral products. The company uses advanced packaging technologies such as Aseptic Blow-Fill-Seal (ABFS) and Injection Stretch Blow Moulding (ISBM) to produce both large-volume and small-volume parenterals across multiple therapeutic segments. In addition to parenterals, Amanta manufactures medical devices, including irrigation solutions, first-aid products, and eye lubricants. Its product portfolio spans fluid therapy, ophthalmic solutions, respiratory care, and diluents, with container volumes ranging from 2ml to 1000ml and a variety of closure systems to suit different applications.

The company sells its medications through both national and international sales channels, as well as through collaborations with Indian and foreign pharmaceutical companies. Amanta sells around 45 generic medicines in India through 320 distributors and stockists. The company also sends branded items to several nations, including as Africa, Latin America, and the UK. As of March 2025, the company has 1,718 personnel working on formulation, development, and quality operations. This lets the corporation make new formulations and improve the ones it already has.

For more details, visit the Amanta Healthcare IPO page.

Amanta Healthcare IPO Details and Objectives

Details

Information

IPO Date

September 1, 2025 to September 3, 2025

Issue Size

1,00,00,000 shares

(aggregating up to ₹126.00 Cr)

Price Band

₹120 to ₹126 per share

Lot Size

119 shares

Listing At

NSE BSE

Purpose of the IPO

  • Funding capital expenditure requirements for civil construction work and towards purchase of equipment, plant and machinery for setting up new manufacturing line of SteriPort at Hariyala, Kheda, Gujarat

  • Funding capital expenditure requirements towards civil construction work, purchase of equipment, plant and machinery for setting up new manufacturing line for SVP at Hariyala, Kheda, Gujarat

  • General corporate purposes

Timeline of Amanta Healthcare IPO

Event

Date

IPO Open Date

Mon, Sep 1, 2025

IPO Close Date

Wed, Sep 3, 2025

Tentative Allotment

Thu, Sep 4, 2025

Initiation of Refunds

Mon, Sep 8, 2025

Credit of Shares to Demat

Mon, Sep 8, 2025

Tentative Listing Date

Tue, Sep 9, 2025

Cut-off time for UPI mandate confirmation

5 PM on September 3, 2025

Pricing & Lot Size of Amanta Healthcare IPO

Price Band for the IPO

  •  ₹120 to ₹126 per share

Minimum Lot Size and Application Details

Application

Lots

Shares

Amount

Retail (Min)

1

119

₹14,994

Retail (Max)

13

1,547

₹1,94,922

S-HNI (Min)

14

1,666

₹2,09,916

S-HNI (Max)

66

7,854

₹9,89,604

B-HNI (Min)

67

7,973

₹10,04,598

How to Apply for the Amanta Healthcare IPO?

Online Application Process

  • Log in to Your Trading Account: Access your trading account through your broker’s platform.

  • Navigate to the IPO Section: Go to the IPO section to view active IPO listings.

  • Select Amanta Healthcare IPO: Find "Amanta Healthcare IPO" and click on the ‘Apply’ button.

  • Enter Application Details: Specify the number of lots (minimum lot size: 119 shares) and the bid price within the range of ₹120 to ₹126 per share.

  • Provide Your UPI ID: Enter your UPI ID for payment authorization. Ensure that sufficient funds are available in your linked account.

  • Review and Submit: Verify all the details entered before submitting the application. Approve the UPI mandate before 5 PM on September 3, 2025, to complete your application process.

Additional Read-  How to Apply for the Amanta Healthcare IPO?

Financial Health and Performance

Key Financial Metrics

  • Total Assets: Grew from ₹374.06 crore in FY23 to ₹381.76 crore as of March 2025.

  • Total income: Reached ₹276.09 crore in FY25.

  • Profit After Tax (PAT): Stood at ₹10.50 crore for March 2025.

  • Net Worth: Recorded at ₹96.39 crore in FY25.

  • Reserves and Surplus: Recorded at ₹67.56 crore (March 2025), growing steadily over the years.

  • EBITDA: Stood at ₹61.05 crore in March 2025.

Recent Performance and Growth Prospects

  • The company’s total assets have shown steady growth over the past few years, reflecting consistent expansion of its operations.

  • Total income has increased gradually, indicating improved business performance and market presence.

  • Profit after tax has remained positive, demonstrating the company’s ability to maintain profitability while managing costs effectively.

  • Net worth has grown steadily, highlighting strengthened financial stability and shareholder value.

  • Reserves and surplus have consistently increased, reflecting prudent financial management and long-term planning.

  • EBITDA trends show healthy operational performance, supported by efficient production and sales strategies.

  • Overall, the company’s performance suggests stable growth prospects, with potential for continued expansion in both domestic and international markets.

Investment Risks and Opportunities

Potential Risks of Investing in the IPO

  • Expansion plans involve significant capital expenditure, and any delays or cost overruns in setting up new manufacturing lines may affect expected returns.

  • Dependence on regulatory approvals and compliance in domestic and international markets could impact the company’s operations and growth if regulations change or approvals are delayed.

Opportunities and Growth Potential

  • The company’s established presence in both domestic and international markets, along with partnerships with pharmaceutical firms, provides scope for expanding its product reach and sales.

  • Planned investments in new manufacturing lines for parenterals and medical devices can enhance production capacity, support innovation, and strengthen the company’s position in the fluid therapy and medical device segments.

Key Performance Indicator (KPI)

KPI

Values

ROE

12.42%

ROCE

13.72%

Debt/Equity

2.02

RoNW

10.89%

PAT Margin

3.86%

EBITDA Margin

22.11%

Price to Book Value

3.77

Amanta Healthcare IPO Registrar & Lead Managers

Registrar

Lead Manager(s)

MUFG Intime India Pvt.Ltd.

Beeline Capital Advisors Pvt.Ltd.

Company Address of Amanta Healthcare Ltd Amanta Healthcare Ltd. 8th Floor, Shaligram CorporatesC.J. Marg Ambli, Ahmedabad, Gujarat, 380058

Phone: 079 67777600

Email: cs@amanta.co.in

Website: https://www.amanta.co.in/

Conclusion

Amanta Healthcare Limited operates in the pharmaceutical and medical device sectors, focusing on the development, manufacturing, and marketing of sterile liquid products and parenterals. The company distributes its products through domestic and international channels and maintains collaborations with Indian and foreign pharmaceutical firms. Its operations cover a wide range of therapeutic segments, supported by formulation, development, and quality teams.

The company has shown steady financial growth in recent years, with gradual increases in total assets, income, and net worth. Expansion plans include the development of new manufacturing lines and continued production of existing formulations. The IPO proceeds are intended for capital expenditure and general corporate purposes.

Interested in more opportunities? Check out our Upcoming IPO section for new listings, and don’t forget to check your IPO allotment status for Amanta Healthcare IPO. 

Share this article: 

Frequently Asked Questions

No result found

search icon

Read More Blogs

Disclaimer :

The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes. The securities are quoted as an example and not as a recommendation. Past performance is not necessarily a guide to future performance.

The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.

Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.

BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.

Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.

[ Read More ]

For more disclaimer, check here : https://www.bajajbroking.in/disclaimer

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

10 lakh+ Users

icon-with-text

4.4 App Rating

icon-with-text

4 Languages

icon-with-text

₹5600+ Cr MTF Book

icon-with-text
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|